RxSight Inc (RXST)

34.50 -1.10 (-3.09%) USD  |  NASDAQ  |  Jan 08, 16:00
34.50 0.00 (0.00%) After-Hours: 20:00
More

RxSight Research and Development Expense (Annual): 29.05M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for RXST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
PROCEPT BioRobotics Corp 48.45M
Perspective Therapeutics Inc 21.31M
Retractable Technologies Inc 0.5812M
Xtant Medical Holdings Inc 1.336M
Catheter Precision Inc 0.475M